![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.675 | 1.60 | 1.70 | - | 0.00 | 07:44:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0095 | -1.76 | 9.07M |
Date | Subject | Author | Discuss |
---|---|---|---|
02/2/2021 09:54 | 10,000 seller selling out | ![]() justtrying1 | |
02/2/2021 09:52 | 7000 share buyer loading up again | ![]() bunz3 | |
02/2/2021 09:52 | Thanks maxplus 2 for above . | ![]() hazl | |
02/2/2021 09:50 | strong buying again | ![]() bunz3 | |
02/2/2021 09:50 | David budd is a useless man | ![]() justtrying1 | |
02/2/2021 09:50 | We have news expected this month any day. | ![]() hazl | |
02/2/2021 09:45 | No point repeating old news No more news for monthsWouldn't be surprised if a new placing is being done with bgf again after they sell outAnd the dilution start againWillKill any rise | ![]() justtrying1 | |
02/2/2021 09:43 | Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR Testing 28 January 2021 28 January 2021 -- genedrive plc, the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences (“Beckman Coulter”) for its Genedrive® 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive’s high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter’s Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit. The Genedrive® 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument. The ready-to-go nature of the test removes many of the fluid dispensing steps required in competitor assays, increasing the overall throughput of the Biomek compared to using a liquid reagent based test formulation. Full automation of the overall PCR workflow can allow laboratories to run large numbers of tests over extended working hours or workstation platforms. Beckman Coulter estimates that this new turnkey solution could process circa 1,000 PCR samples per Biomek workstation installed during a standard 8-hour working day, using just a 0.5 full-time-equivalent in technician time for processing. From Sampleshop. | ![]() hazl | |
02/2/2021 09:41 | My best guess,as well, is that we have some investors here,as opposed to traders. | ![]() hazl | |
02/2/2021 09:40 | Dnt be fooled big bgf sells in the off | ![]() justtrying1 | |
02/2/2021 09:40 | Buy now for 83p | ![]() justtrying1 | |
02/2/2021 09:40 | nt to buy again ,looking like they needing shares | ![]() bunz3 | |
02/2/2021 09:39 | This has some news expected very soon so it's likely to keep up momentum in my opinion. | ![]() hazl | |
02/2/2021 09:38 | Amuses me how they bring out their old posters names too,to make it seem like more than one person. I suppose it's a kind of jealousy that they can't spot the good ones before they go up. | ![]() hazl | |
02/2/2021 09:34 | I remember, I first those shares you mentioned at 24p early last year, still hold, hope you well | ![]() amrishbhim | |
02/2/2021 09:34 | A breather before the next surge? | ![]() hazl | |
02/2/2021 09:33 | liike how quickly any sells being bought up | ![]() bunz3 | |
02/2/2021 09:31 | buying volume looking so strong ,the NT to buy so annoying this morning | ![]() bunz3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions